Clear Harbor Asset Management LLC Sells 2,948 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Clear Harbor Asset Management LLC cut its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 32.9% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 6,003 shares of the company's stock after selling 2,948 shares during the quarter. Clear Harbor Asset Management LLC's holdings in GE HealthCare Technologies were worth $469,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently made changes to their positions in GEHC. State Street Corp increased its position in GE HealthCare Technologies by 7.8% in the third quarter. State Street Corp now owns 18,615,890 shares of the company's stock worth $1,747,101,000 after purchasing an additional 1,347,114 shares during the period. Geode Capital Management LLC increased its position in GE HealthCare Technologies by 7.2% in the third quarter. Geode Capital Management LLC now owns 10,977,757 shares of the company's stock worth $1,026,898,000 after purchasing an additional 733,819 shares during the period. D1 Capital Partners L.P. acquired a new stake in GE HealthCare Technologies in the third quarter worth about $268,159,000. Charles Schwab Investment Management Inc. increased its position in GE HealthCare Technologies by 12.0% in the third quarter. Charles Schwab Investment Management Inc. now owns 2,710,938 shares of the company's stock worth $254,422,000 after purchasing an additional 290,019 shares during the period. Finally, Van ECK Associates Corp acquired a new stake in GE HealthCare Technologies in the third quarter worth about $208,513,000. 82.06% of the stock is currently owned by institutional investors and hedge funds.

GE HealthCare Technologies Stock Performance

Shares of GEHC stock traded down $0.01 during trading on Wednesday, reaching $87.33. 2,379,496 shares of the company's stock were exchanged, compared to its average volume of 3,139,390. The company has a quick ratio of 0.98, a current ratio of 1.23 and a debt-to-equity ratio of 1.12. The stock has a market capitalization of $39.90 billion, a PE ratio of 23.99, a PEG ratio of 2.80 and a beta of 1.11. GE HealthCare Technologies Inc. has a twelve month low of $71.31 and a twelve month high of $94.55. The firm's fifty day moving average price is $82.08 and its 200-day moving average price is $84.58.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last posted its earnings results on Wednesday, October 30th. The company reported $1.14 earnings per share for the quarter, topping analysts' consensus estimates of $1.06 by $0.08. The business had revenue of $4.86 billion for the quarter, compared to analyst estimates of $4.87 billion. GE HealthCare Technologies had a return on equity of 25.19% and a net margin of 8.56%. The firm's revenue was up .9% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.99 EPS. As a group, sell-side analysts anticipate that GE HealthCare Technologies Inc. will post 4.3 EPS for the current year.

GE HealthCare Technologies Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 14th will be issued a dividend of $0.035 per share. The ex-dividend date is Tuesday, January 14th. This is a positive change from GE HealthCare Technologies's previous quarterly dividend of $0.03. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.16%. GE HealthCare Technologies's payout ratio is presently 3.85%.

Insider Buying and Selling

In other GE HealthCare Technologies news, CEO Roland Rott sold 3,577 shares of the company's stock in a transaction on Wednesday, November 6th. The stock was sold at an average price of $86.48, for a total value of $309,338.96. Following the transaction, the chief executive officer now directly owns 24,298 shares of the company's stock, valued at $2,101,291.04. This represents a 12.83 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. 0.27% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

A number of brokerages recently commented on GEHC. Wells Fargo & Company lifted their price objective on GE HealthCare Technologies from $95.00 to $96.00 and gave the stock an "overweight" rating in a research report on Thursday, October 31st. UBS Group lowered GE HealthCare Technologies from a "neutral" rating to a "sell" rating and decreased their target price for the stock from $84.00 to $74.00 in a research report on Thursday, September 26th. Evercore ISI boosted their target price on GE HealthCare Technologies from $98.00 to $102.00 and gave the stock an "outperform" rating in a research report on Tuesday, October 1st. Stifel Nicolaus boosted their target price on GE HealthCare Technologies from $100.00 to $102.00 and gave the stock a "buy" rating in a research report on Monday, September 30th. Finally, Jefferies Financial Group upgraded GE HealthCare Technologies from a "hold" rating to a "buy" rating and boosted their target price for the stock from $95.00 to $103.00 in a research report on Wednesday, January 8th. One research analyst has rated the stock with a sell rating, four have issued a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $96.00.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.